510(k) submission accepted by FDA, K-number issued

July 2018

ARS Summer Sinus Symposium Exhibitor

July 2018

Abstract Accepted for Oral Presentation at American Rhinologic Society Annual Meeting

July 2018

1st Medical Advisory Board Meeting

June 2018

71 patient double-blind RCT completed at Stanford Sinus Center

May 2018

Pivotal study completed for FDA submission, met agreed endpoint

May 2018

Tivic Health files international patent applications

April 2018

Maureen Perou, MBA joins Tivic Health as VP of Marketing

March 2018

1st national press release

March 2018

Future Healthcare Event 2018 Exhibitor

March 2018

Successful Usability testing conducted

February 2018

Double-blind, randomized, placebo-controlled study initiated at Stanford Sinus Center

January 2018

Blake Gurfein, PhD joins Tivic Health as VP of Research and Scientific Affairs

January 2018

Dr Peter Hwang joins Tivic Health’s medical advisory board

January 2018

FDA pre-submission meeting validates clinical protocol for pivotal study

October 2017

Erik Hasenoehrl, Senior Fellow, P&G, joins Tivic Health advisory board

October 2017

1st employee, Chandreskhar Durisety, PhD joins Tivic Health as VP of Manufacturing

August 2017

Carolyn McMakin, pioneer in microcurrent for medical use joins Tivic Health advisory board

June 2017

FDA pre-submission meeting validates 510(k) regulatory pathway

June 2017

Dr Subinoy Das joins Tivic Health medical advisory board.

May 2017

First proof-of-concept prototypes completed

January 2017

Company Incorporated

September 2016

Stay Informed!

Join our mailing list for Tivic news, offers and more